Cargando…

Glyoxalase 1-knockdown in human aortic endothelial cells – effect on the proteome and endothelial function estimates

Methylglyoxal (MG), an arginine-directed glycating agent, is implicated in diabetic late complications. MG is detoxified by glyoxalase 1 (GLO1) of the cytosolic glyoxalase system. The aim was to investigate the effects of MG accumulation by GLO1-knockdown under hyperglycaemic conditions in human aor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stratmann, Bernd, Engelbrecht, Britta, Espelage, Britta C., Klusmeier, Nadine, Tiemann, Janina, Gawlowski, Thomas, Mattern, Yvonne, Eisenacher, Martin, Meyer, Helmut E., Rabbani, Naila, Thornalley, Paul J., Tschoepe, Diethelm, Poschmann, Gereon, Stühler, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127188/ https://www.ncbi.nlm.nih.gov/pubmed/27898103 http://dx.doi.org/10.1038/srep37737

Ejemplares similares

Intracellular Accumulation of Methylglyoxal by Glyoxalase 1 Knock Down Alters Collagen Homoeostasis in L6 Myoblasts
por: Stratmann, Bernd, et al.
Publicado: (2017)

Impact of GLO1 Knock Down on GLUT4 Trafficking and Glucose Uptake in L6 Myoblasts
por: Engelbrecht, Britta, et al.
Publicado: (2013)

Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors
por: Rabbani, Naila, et al.
Publicado: (2022)

Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics
por: Rabbani, Naila, et al.
Publicado: (2016)

Chronic Hyperglycaemia Inhibits Tricarboxylic Acid Cycle in Rat Cardiomyoblasts Overexpressing Glucose Transporter Type 4
por: Stratmann, Bernd, et al.
Publicado: (2022)

Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress
por: Kurz, Alexander, et al.
Publicado: (2010)

Glycolytic overload-driven dysfunction of periodontal ligament fibroblasts in high glucose concentration, corrected by glyoxalase 1 inducer
por: Ashour, Amal, et al.
Publicado: (2020)

Heart in Diabetes: Not Only a Macrovascular Disease
por: Stratmann, Bernd, et al.
Publicado: (2011)

IDF21-0230 Anti-inflammatory activity of glyoxalase-1 inducer supports further evaluation for prevention of COVID-19
por: Xue, M., et al.
Publicado: (2022)

Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome
por: Alhujaily, Muhanad, et al.
Publicado: (2021)

Imidazopurinones are markers of physiological genomic damage linked to DNA instability and glyoxalase 1-associated tumour multidrug resistance
por: Thornalley, Paul J., et al.
Publicado: (2010)

Shifting the Disease Management Paradigm From Glucose: What are the pros?
por: Stirban, Alin, et al.
Publicado: (2009)

Peripheral oscillometric arterial performance does not depict coronary status in patients with type 2 diabetes mellitus
por: Jaeger, Magdalene, et al.
Publicado: (2021)

Activation of the unfolded protein response in high glucose treated endothelial cells is mediated by methylglyoxal
por: Irshad, Zehra, et al.
Publicado: (2019)

Autoregulatory “Multitasking” at Endothelial Cell Junctions by Junction-Associated Intermittent Lamellipodia Controls Barrier Properties
por: Seebach, Jochen, et al.
Publicado: (2021)

Methylglyoxal and glyoxalase 1—a metabolic stress pathway-linking hyperglycemia to the unfolded protein response and vascular complications of diabetes
por: Rabbani, Naila
Publicado: (2022)

Schulungskonzepte mithilfe von Telemedizin in der pädiatrischen Diabetologie
por: Biester, Sarah, et al.
Publicado: (2022)

Activation of NF-E2–Related Factor-2 Reverses Biochemical Dysfunction of Endothelial Cells Induced by Hyperglycemia Linked to Vascular Disease
por: Xue, Mingzhan, et al.
Publicado: (2008)

Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin‐treated, apolipoprotein E‐deficient mice
por: Geoffrion, Michèle, et al.
Publicado: (2014)

Knockdown of Glyoxalase 1 Mimics Diabetic Nephropathy in Nondiabetic Mice
por: Giacco, Ferdinando, et al.
Publicado: (2014)

Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET)
por: Xue, Mingzhan, et al.
Publicado: (2017)

Liraglutide and DPP-4 inhibitors – side effects comparative clinical study
por: TIMOFTE, LUMINIŢA, et al.
Publicado: (2013)

Protein glycation – biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine
por: Rabbani, Naila, et al.
Publicado: (2021)

An Introduction to the Special Issue “Protein Glycation in Food, Nutrition, Health and Disease”
por: Rabbani, Naila, et al.
Publicado: (2022)

Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
por: Spanos, Christos, et al.
Publicado: (2018)

Zebrafish heart development is regulated via glutaredoxin 2 dependent migration and survival of neural crest cells
por: Berndt, Carsten, et al.
Publicado: (2014)

Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
por: Spanos, Christos, et al.
Publicado: (2018)

Glyoxalase I reduces glycative and oxidative stress and prevents age-related endothelial dysfunction through modulation of endothelial nitric oxide synthase phosphorylation
por: Jo-Watanabe, Airi, et al.
Publicado: (2014)

Mass spectrometric determination of early and advanced glycation in biology
por: Rabbani, Naila, et al.
Publicado: (2016)

Dicarbonyl stress, protein glycation and the unfolded protein response
por: Rabbani, Naila, et al.
Publicado: (2021)

Hexokinase-2-Linked Glycolytic Overload and Unscheduled Glycolysis—Driver of Insulin Resistance and Development of Vascular Complications of Diabetes
por: Rabbani, Naila, et al.
Publicado: (2022)

Glyoxalase Goes Green: The Expanding Roles of Glyoxalase in Plants
por: Sankaranarayanan, Subramanian, et al.
Publicado: (2017)

Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients
por: Bracht, Thilo, et al.
Publicado: (2016)

Protein Glycation in Plants—An Under-Researched Field with Much Still to Discover
por: Rabbani, Naila, et al.
Publicado: (2020)

The GABARAP Co-Secretome Identified by APEX2-GABARAP Proximity Labelling of Extracellular Vesicles
por: Sanwald, Julia L., et al.
Publicado: (2020)

OutCyte: a novel tool for predicting unconventional protein secretion
por: Zhao, Linlin, et al.
Publicado: (2019)

Secretomics—A Key to a Comprehensive Picture of Unconventional Protein Secretion
por: Poschmann, Gereon, et al.
Publicado: (2022)

Reversal of Insulin Resistance in Overweight and Obese Subjects by trans-Resveratrol and Hesperetin Combination—Link to Dysglycemia, Blood Pressure, Dyslipidemia, and Low-Grade Inflammation
por: Rabbani, Naila, et al.
Publicado: (2021)

Glyoxalases in Urological Malignancies
por: Antognelli, Cinzia, et al.
Publicado: (2018)

A Glyoxalase-1 Knockdown Does Not Have Major Short Term Effects on Energy Expenditure and Atherosclerosis in Mice
por: Wortmann, Markus, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_csfsu0lclnghl8euqbi9r0h7h5